Joshua Bote

| USA TODAY
More than 430,000 bottles of painkillers under the Excedrin brand have been recalled due to a manufacturing defect that may have left holes in the bottom of Excedrin bottles.GlaxoSmithKline (GSK), Excedrin’s manufacturer, announced the recall Wednesday for many of its aspirin and acetaminophen-based, over-the-counter products sold nationwide between March 2018 and September 2020.The products — sold under the names Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets — violated the Poison Prevention Packaging Act, which mandates childproof packaging for over-the-counter and prescription drugs, among other possibly hazardous household products.A full list of products can be found on the GSK website.The Excedrin bottles were supplied by a third-party manufacturer, per a statement from GSK, and were sold nationwide and online. No injuries or incidents have been reported.Excedrin bottles without holes in its bottoms can be kept and used as directed, per a notice posted on the Consumer Product Safety Commission website. Those with holes, however, can be returned to GlaxoSmithKline for a full refund.The company issued a “stop sale” alert in October, which was not a full recall.Follow Joshua Bote on Twitter: @joshua_bote.


Source link

FINANCIAL NEWS